T1	CHEM 56 71	dexmedetomidina
#1	AnnotatorNotes T1	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T2	CHEM 75 83	propofol
#2	AnnotatorNotes T2	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T3	PROC 187 197	implantado
#3	AnnotatorNotes T3	C0021107; Implantation procedure; Therapeutic or Preventive Procedure
T4	DISO 221 244	Enfermedad de Parkinson
#4	AnnotatorNotes T4	C0030567; Parkinson Disease; Disease or Syndrome
T5	PROC 457 466	protocolo
#5	AnnotatorNotes T5	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T6	PROC 376 400	consentimiento informado
#6	AnnotatorNotes T6	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T7	PROC 605 619	ensayo clínico
#7	AnnotatorNotes T7	C0008976; Clinical Trials; Research Activity
T8	ANAT 726 734	cerebral
#8	AnnotatorNotes T8	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T9	DISO 748 771	enfermedad de Parkinson
#9	AnnotatorNotes T9	C0030567; Parkinson Disease; Disease or Syndrome
T10	ANAT 775 793	núcleo subtalámico
#10	AnnotatorNotes T10	C0152355; Structure of subthalamic nucleus; Body Part, Organ, or Organ Component | C1281060; Entire subthalamic nucleus; Body Part, Organ, or Organ Component | C1284083; Entire luys' nucleus; Body Part, Organ, or Organ Component
T11	ANAT 796 808	globo pálido
#11	AnnotatorNotes T11	C0017651; Globus Pallidus; Body Part, Organ, or Organ Component | C1284620; Entire globus pallidus; Body Part, Organ, or Organ Component
T12	PROC 697 743	colocación de un estimulador cerebral profundo
T13	PROC 997 1011	ensayo clínico
#12	AnnotatorNotes T13	C0008976; Clinical Trials; Research Activity
T14	DISO 1032 1049	hipersensibilidad
#13	AnnotatorNotes T14	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T15	CHEM 1070 1078	propofol
#14	AnnotatorNotes T15	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T16	DISO 1083 1099	Bloqueo cardíaco
#15	AnnotatorNotes T16	C0018794; Heart Block; Disease or Syndrome
T17	DISO 1136 1159	Hipotensión sintomática
#16	AnnotatorNotes T17	C0863113; Hypotension symptomatic; Pathologic Function
T18	DISO 1177 1203	enfermedad cerebrovascular
#17	AnnotatorNotes T18	C0007820; Cerebrovascular Disorders; Disease or Syndrome
T19	ANAT 115 123	cerebral
#18	AnnotatorNotes T19	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T20	PROC 814 822	sedación
#19	AnnotatorNotes T20	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T21	CHEM 1052 1067	dexmedetomidina
#20	AnnotatorNotes T21	C0113293; dexmedetomidine; Organic Chemical · Pharmacologic Substance
T22	ANAT 1091 1099	cardíaco
#21	AnnotatorNotes T22	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T23	Date 13 17	2014
T24	PHYS 105 123	actividad cerebral
#22	AnnotatorNotes T24	C0443158; Brain activity; Physiologic Function
T26	DEVI 175 186	estimulador
#23	AnnotatorNotes T26	C0086222; Enhancer of transcription; Nucleic Acid, Nucleoside, or Nucleotide | C0175727; Stimulator; Medical Device
T27	LIVB 281 290	pacientes
#24	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 507 515	paciente
#25	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 537 549	investigador
#26	AnnotatorNotes T29	C0035173; Research Personnel; Professional or Occupational Group
T30	LIVB 627 635	paciente
#27	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Age 647 660	mayor de edad
T32	LIVB 668 676	paciente
#28	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	DEVI 714 734	estimulador cerebral
#29	AnnotatorNotes T33	C0596213; brain electronic stimulator; Medical Device | C0810489; Stimulators, Electrical, Brain; Medical Device
T34	LIVB 895 904	pacientes
#30	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T36	Neg_cue 1117 1120	sin
T37	DEVI 1121 1131	marcapasos
#31	AnnotatorNotes T37	C0030163; Artificial cardiac pacemaker; Medical Device
T38	LIVB 1164 1172	Paciente
#32	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 1214 1259	Paciente embarazada o en período de lactancia
#33	AnnotatorNotes T39	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T41	PHYS 1223 1233	embarazada
#34	AnnotatorNotes T41	C0032961; Pregnancy; Organism Function
T25	LIVB 845 863	médico responsable
#35	AnnotatorNotes T25	C4708568; Medically responsible investigator; Professional or Occupational Group
T35	PHYS 1250 1259	lactancia
#36	AnnotatorNotes T35	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A1	Assertion T37 Negated
A2	Status T14 History_of
T40	Neg_cue 967 969	no
T42	Observation 981 1011	incluidos en el ensayo clínico
A3	Assertion T42 Negated
#37	AnnotatorNotes T42	C1278516; Patient participation status; Finding
R1	Negation Arg1:T40 Arg2:T42	
R3	Causes Arg1:T21 Arg2:T14	
R4	Causes Arg1:T15 Arg2:T14	
T43	Quantifier_or_Qualifier 1103 1116	2º o 3º grado
R5	Location_of Arg1:T22 Arg2:T16	
R6	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T43	
R7	Negation Arg1:T36 Arg2:T37	
R8	Experiences Arg1:T38 Arg2:T18	
T44	Quantifier_or_Qualifier 1204 1209	grave
#38	AnnotatorNotes T44	C1547227;Severe - Severity of Illness Code; Intellectual Product
R9	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T44	
R10	Experiences Arg1:T39 Arg2:T41	
R11	Experiences Arg1:T39 Arg2:T35	
R12	Location_of Arg1:T19 Arg2:T24	
T45	Observation 46 52	Efecto
#39	AnnotatorNotes T45	C1518681; Outcome of Therapy; Finding (?)
R13	Causes Arg1:T1 Arg2:T45	
R14	Causes Arg1:T2 Arg2:T45	
T46	Quantifier_or_Qualifier 124 132	profunda
#40	AnnotatorNotes T46	C0205125; Deep (qualifier value); Spatial Concept
R15	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T46	
R16	Used_for Arg1:T26 Arg2:T3	
T47	Observation 297 348	cumplir todos los siguientes criterios de inclusión
#41	AnnotatorNotes T47	C4329786; Eligibility Criteria Met By Subject; Finding
R19	Has_Age Arg1:T30 Arg2:T31	
T48	Observation 564 600	cumplir con todos los requerimientos
#42	AnnotatorNotes T48	C0582783; Ability to comply with treatment; Finding (?)
R21	Used_for Arg1:T33 Arg2:T12	
R22	Location_of Arg1:T8 Arg2:T12	
#43	AnnotatorNotes T12	C4069029; Neuro: Deep brain stimulator implant; Therapeutic or Preventive Procedure
R23	Experiences Arg1:T32 Arg2:T12	
R24	Experiences Arg1:T32 Arg2:T9	
R25	Location_of Arg1:T10 Arg2:T12	
R26	Location_of Arg1:T11 Arg2:T12	
R27	Experiences Arg1:T32 Arg2:T20	
R28	Before Arg1:T20 Arg2:T12	
T49	Observation 353 362	Capacidad
#44	AnnotatorNotes T49	C1299581;Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R29	Overlap Arg1:T49 Arg2:T6	
T50	Observation 415 452	deseo de cumplir todos los requisitos
T51	PROC 489 496	estudio
#45	AnnotatorNotes T51	C0008976; Clinical Trials; Research Activity
R30	Overlap Arg1:T50 Arg2:T51	
R31	Before Arg1:T6 Arg2:T51	
R2	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T42	
#46	AnnotatorNotes T43	C0443298; Second degree; Qualitative Concept | C0443323; Third degree; Qualitative Concept
R17	Overlap Arg1:T16 Arg2:T37	
A4	Experiencer T38 Patient
A5	Experiencer T34 Patient
A6	Experiencer T39 Patient
A7	Experiencer T27 Patient
A8	Experiencer T28 Patient
A9	Experiencer T29 Other
A10	Experiencer T30 Patient
A11	Experiencer T32 Patient
A12	Experiencer T25 Other
A13	Status T12 Future
A14	Status T33 Future
A15	Status T20 Future
